Aurinia Pharmaceuticals Inc. Human Resources Contracts & Agreements
15 Contracts & Agreements
- Bonus & Incentive Agreements (1 contract)
- Employment Agreements (10)
- Separation Agreements (4)
- Form of Restricted Stock Unit Award under the Equity Incentive Plan (Filed With SEC on February 28, 2023)
- Separation Agreement between Aurinia Pharmaceuticals Inc. and Rob Huizinga dated October 20, 2022 (Filed With SEC on November 3, 2022)
- Separation Agreement between Aurinia Pharmaceuticals Inc. and Neil Solomons dated October 20, 2022 (Filed With SEC on November 3, 2022)
- Separation Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated (Filed With SEC on November 3, 2022)
- Employment Agreement between Aurinia Pharma U.S. Inc., and Scott Habig dated June 27, 2022 (Filed With SEC on August 4, 2022)
- Employment Agreement between Aurinia Pharma U.S. Inc., and Volker Knappertz, M.D., dated July 11, 2022 (Filed With SEC on August 4, 2022)
- Separation Agreement between Aurinia Pharma U.S., Inc. and Erik Eglite dated October 26, 2020 (Filed With SEC on February 24, 2021)
- Employment Agreement between the Registrant and Neil Solomons dated October 1, 2017 (Filed With SEC on February 24, 2021)
- Employment Agreement between the Registrant and Stephen Robertson dated September 29, 2020 (Filed With SEC on February 24, 2021)
- Employment Agreement between Aurinia Pharma U.S. Inc. and Joe Miller dated April 8, 2020 (Filed With SEC on February 24, 2021)
- Employment Agreement between the Registrant and Michael Martin dated October 1, 2017 (Filed With SEC on February 24, 2021)
- Employment Agreement between the Registrant and Robert Huizinga dated October 1, 2017 (Filed With SEC on February 24, 2021)
- Employment Agreement between Aurinia Pharma U.S. Inc. and Max Donley dated July 15, 2019 (Filed With SEC on February 24, 2021)
- Employment Agreement between Aurinia Pharma U.S. Inc. and Max Colao dated February 10, 2020 (Filed With SEC on February 24, 2021)
- Employment Agreement between Aurinia Pharma U.S., Inc. and Peter Greenleaf dated April 11, 2019 (Filed With SEC on February 24, 2021)
